DONDI, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 5.298
NA - Nord America 4.511
AS - Asia 3.899
Continente sconosciuto - Info sul continente non disponibili 735
SA - Sud America 311
AF - Africa 80
OC - Oceania 14
Totale 14.848
Nazione #
US - Stati Uniti d'America 4.344
GB - Regno Unito 1.970
SG - Singapore 1.196
CN - Cina 1.137
DE - Germania 865
IT - Italia 522
SE - Svezia 518
RU - Federazione Russa 401
BD - Bangladesh 302
HK - Hong Kong 283
VN - Vietnam 247
FR - Francia 222
NL - Olanda 217
TR - Turchia 214
BR - Brasile 199
KR - Corea 167
UA - Ucraina 164
IE - Irlanda 134
IN - India 127
FI - Finlandia 107
EU - Europa 102
CA - Canada 97
CO - Colombia 43
JP - Giappone 36
PH - Filippine 36
CI - Costa d'Avorio 31
ID - Indonesia 31
GR - Grecia 29
IQ - Iraq 28
MX - Messico 23
ES - Italia 19
AR - Argentina 17
BE - Belgio 17
PL - Polonia 16
DK - Danimarca 15
RO - Romania 15
ZA - Sudafrica 14
AU - Australia 12
CL - Cile 12
TW - Taiwan 12
CH - Svizzera 11
EC - Ecuador 10
IL - Israele 10
SA - Arabia Saudita 10
UY - Uruguay 10
AT - Austria 9
VE - Venezuela 9
CR - Costa Rica 8
JM - Giamaica 8
MY - Malesia 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 7
NO - Norvegia 7
PT - Portogallo 7
UZ - Uzbekistan 7
RS - Serbia 6
HR - Croazia 5
HU - Ungheria 5
JO - Giordania 5
PA - Panama 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
EG - Egitto 4
HN - Honduras 4
NP - Nepal 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
IR - Iran 3
KE - Kenya 3
NI - Nicaragua 3
PE - Perù 3
PR - Porto Rico 3
SN - Senegal 3
AO - Angola 2
CG - Congo 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BM - Bermuda 1
BZ - Belize 1
CU - Cuba 1
Totale 14.197
Città #
Southend 1.847
Singapore 623
Ashburn 402
Hanover 379
Chandler 349
Seattle 274
Hong Kong 269
San Jose 255
Beijing 224
Council Bluffs 205
Santa Clara 196
Princeton 172
Milan 167
Dallas 162
Wilmington 144
Dublin 132
Redmond 126
New York 119
Jacksonville 117
Ann Arbor 113
Los Angeles 103
Woodbridge 98
Fairfield 92
Frankfurt am Main 86
Nanjing 82
Ho Chi Minh City 78
Sakarya 78
Lauterbourg 69
Des Moines 68
Mountain View 67
Buffalo 63
Boardman 62
Moscow 58
Munich 57
Dearborn 55
Guangzhou 54
Houston 52
Toronto 51
Shanghai 50
Bengaluru 47
Hanoi 47
Shenyang 43
Somerville 42
Andover 40
Cambridge 39
Bogotá 36
Jinan 33
Abidjan 31
Athens 29
Zhengzhou 29
Tokyo 28
Grafing 26
Norwalk 26
Rome 26
Cangzhou 25
Tianjin 25
Redwood City 24
Changsha 23
Nanchang 23
Serra 23
Helsinki 22
The Dalles 22
Bitonto 21
Columbus 21
Hangzhou 21
Medford 21
São Paulo 21
Mannheim 20
Hefei 19
Da Nang 18
Jakarta 18
San Diego 18
Lanzhou 17
Turin 17
Ningbo 16
Berlin 15
Brussels 15
Kiez 15
Hebei 14
Jiaxing 14
Fuzhou 13
Palermo 13
Phoenix 13
Istanbul 12
London 12
Naples 12
Roxbury 12
Haikou 11
Warsaw 11
Haiphong 10
Sunnyvale 10
Taizhou 10
Auburn Hills 9
Dhaka 9
Atlanta 8
Baghdad 8
Belo Horizonte 8
Chicago 8
Montevideo 8
Quito 8
Totale 8.833
Nome #
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 452
Expression and differential effects of the activation of glucocorticoid receptors in mouse gonadotropin-releasing hormone neurons 354
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol 345
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies 328
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion 326
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 279
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 278
Biologia Cellulare 271
Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study 259
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) 248
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism 230
Aging and the hypothalamo-pituitary-testicular axis in the rat 207
Endocrinology of aging 206
Role of glucocorticoids in the migration of immature LHRH neurons 200
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 199
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion 198
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 194
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 191
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH) 191
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 190
Role of Estrogen Receptor beta on prostate cancer cell migration 189
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 189
Role of estrogen receptor beta in the progression of prostate cancer 188
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors 187
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 185
Expression and role of glucocorticoid receptors in mouse neurons secretine gonadotropin releasing hormons 182
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 182
Dosimetric analysis of phenolic solid state pellets exposed to radio-therapeutic photon and electron beams through electron spin resonance technique=Analisi dosimetrica di composti fenolici irradiati con fasci clinici di fotoni ed elettroni tramite spettroscopia di risonanza di spin elettronico 182
Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat 181
Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat 181
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor 180
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines 177
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system 176
Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat 176
Regolazione del sistema attivatore del plasminogeno da parte degli ormoni glucocorticoidi nella progressione metastatica del cancro prostatico 175
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 174
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 173
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer 168
Endocrine responses to naloxone in young and old male rats. 168
Hypothalamic ß-endorphin and brain mu opiate receptor concentrations in male rat after restraint stress 167
Biology of hypothalamic neurons producing gonadotropin-releasing hormone (GnRH): new information on the use of immortalized cells secreting GnRH 167
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 166
In vivo growth properties and molecular marker expression of DU145 human prostate tumor cells expressing recombinant androgen receptor 165
Dexamethasone modulates differentiation and motility of SK-N-SH human neuroblastoma cells 165
Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat 165
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 164
Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145 162
The metastatic progression of prostate cancer effect of LHRH analogs on plasminogen activator system 162
Binding characteristics of delta opioid receptors in different regions of the brain of young and old male rats as studied with the highly selective ligand [D-Pen2-D-Pen5] enkephalin 158
Gonadal steroid modulation of brain opioid systems 157
LRHR as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action 153
The EGF/TGFalpha system as an autocrine growth stimulatory loop in LNCaP cells 153
Growth factors in steroid-responsive prostatic tumor cells 152
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 151
Effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano 150
Morphine stimulates prolactin release in normal but not in castrated male rats 149
Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion 149
Effect of glucocorticoids on the plasminogen activator system in the metastatic progression of prostate cancer 148
Involvment of the glucocorticoid receptor in the migration of GN11 LHRH neurons 147
Distribution of kappa opioid receptors in the brain of young and old male rats 147
La progressione metastatica del cancro prostatico umano: effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno 146
Involvment of Glucocorticoid receptors in the migratore activity of immortalized GnRH secreting neurons 141
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice 141
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145 140
Effect of LHRH analogs on the Urokinase Receptor in the metastatic progression of prostate cancer 139
Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion 139
Meccanismo d'azione degli ormoni 138
Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids 137
Epigenetic control of pi3k/akt activity in prostate cancer during hormone manipulation 137
GnRH analogues inhibit the plasminogen activator system and the metastatic progression of prostate cancer 136
Soluble urokinase-type plasminogen activation receptor inhibits prostate cancer cell growth and invasion 134
Peptide-steroid interactions in the modulation of the hypothalamic-pituitary axis 133
Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat 132
Sex steroids and brain opioid receptors 132
Effects of steroids on the brain opioid system 131
The metastatic progression of prostate cancer : effect of LHRH analogs on plasminogen activator system 129
Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats 129
Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP 129
Role of GnRH analogs in the control of the plasminogen activator system in human prostate cancer cell lines 122
Effect of ovarian steroids on the concentration of mu opiate receptors in different regions of the brain of the female rat 115
Effetto degli analoghi dell’LHRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano” 110
Mechanism of action of interleukin-1 in modulating gonadotropin secretion. In vivo and in vitro studies 107
Effects of ovarian hormones on brain opioid binding sites in castrated female rats 95
Totale 14.848
Categoria #
all - tutte 37.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.180 0 0 121 60 104 67 73 88 214 112 140 201
2022/20231.173 138 85 96 142 146 234 28 123 90 7 72 12
2023/2024686 25 62 35 41 201 44 25 32 5 11 102 103
2024/20251.694 55 101 15 149 172 75 49 187 81 198 114 498
2025/20263.576 362 162 348 208 354 220 410 180 402 325 348 257
2026/2027499 233 247 19 0 0 0 0 0 0 0 0 0
Totale 14.848